← Eichor
Study identifier: NCT02114450 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Human-Machine System for the H2 Lower Limb Exoskeleton

Condition: Stroke · Hemiparesis  ·  Sponsor: University of Houston

PhaseNA
Planned participants60
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersYes

About this study

This research study will investigate the use of smart lower limb robotic exoskeleton (developed by the CSIC, Spain) in rehabilitation after stroke. It will compare robotic-assisted rehabilitation with supervised motor practice. Additionally, it will also examine the use of noninvasive scalp electroencephalography (EEG) to learn specific brain wave patterns associated with learning to walk on the powered lower limb exoskeleton. The findings will be used to understand human-robot interaction and to design smart orthotic devices that can be controlled by thought activity and assist those that have lost all or part of their walking abilities.

This description comes directly from the study's public registry record.

Talk to the study team

Jose L Contreras-Vidal, PhD  ·  713-743-4429  ·  jlcontreras-vidal@UH.EDU

Always discuss trial participation with your own doctor first.

Locations (2)

TIRR Memorial Hermann HospitalHouston, Texas, United StatesNot Yet Recruiting
University of HoustonHouston, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02114450